Prediction of the effect of chemotherapy and prognosis based on gene and metabolome analysis by specimen collected by EUSFNA on pancreatic cancer

Prediction of the effect of chemotherapy and prognosis based on gene and metabolome analysis by specimen collected by EUSFNA on pancreatic cancer - Prediction of the effect of chemotherapy and prognosis based on gene and metabolome analysis by specimen collected by EUSFNA on pancreatic cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026261

Enrollment

250

Registered

2017-02-22

Start date

2016-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: To be able to give informed consent

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Relation between frequency of genetic mutation and effect of chemotherapy	—

Secondary

Measure	Time frame
Relation between metabolite and effect of chemotherapy Relation between frequency of genetic mutation and metabolite of tissue and blood	—

Countries

Japan

Contacts

Public ContactAtsuhiro Masuda

Kobe University Hospital Dep. of Gastroenterology

atmasuda@med.kobe-u.ac.jp078-382-6305

Outcome results